> top > projects > semrep-sample > docs > PubMed:1482376 > annotations
semrep-sample Home  

PubMed:1482376 JSONTXT 13 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
E1-ti-1 0-17 cui:C0023791 denotes Alpha-lipoic acid
E2-ti-1 23-29 cui:C0237399 denotes potent
E3-ti-1 30-39 cui:C0243077 denotes inhibitor
E4-ti-1 43-53 cui:C0079904 denotes NF-kappa B
T1 54-64 STIMULATES denotes activation
E5-ti-1 68-81 cui:C0427861 denotes human T cells
E1-ab-1 83-117 cui:C0001175 denotes Acquired immunodeficiency syndrome
T2 125-132 CAUSES denotes results
E2-ab-1 138-147 cui:C0021311 denotes infection
E3-ab-1 155-183 cui:C0019682 denotes human immunodeficiency virus
E1-ab-2 195-215 cui:C0023978 denotes long terminal repeat
E2-ab-2 222-228 cui:C0205147 denotes region
E3-ab-2 232-248 cui:C0486959 denotes HIV proviral DNA
E4-ab-2 258-271 cui:C0005456 denotes binding sites
E5-ab-2 276-298 cui:C0079904 denotes nuclear factor kappa B
E6-ab-2 322-347 cui:C1336776 denotes transcriptional activator
T3 359-367 AFFECTS denotes regulate
E7-ab-2 368-371 cui:C0020114 denotes HIV
E8-ab-2 368-371 cui:C0021051 denotes HIV
E9-ab-2 368-382 cui:C0042767 denotes HIV activation
E1-ab-3 384-390 cui:C0332185 denotes Recent
E2-ab-3 391-399 cui:C0243095 denotes findings
E3-ab-3 426-449 cui:C0162772 denotes reactive oxygen species
E4-ab-3 459-487 cui:C0086982 denotes signal transduction pathways
E5-ab-3 499-509 cui:C0079904 denotes NF-kappa B
T4 510-520 STIMULATES denotes activation
E1-ab-4 526-533 cui:C0150312 denotes present
E2-ab-4 534-539 cui:C0008972 denotes study
E3-ab-4 566-578 cui:C0003402 denotes antioxidants
E4-ab-4 595-598 cui:C0162772 denotes ROS
T7 616-626 STIMULATES denotes activation
T8 616-626 STIMULATES denotes activation
E5-ab-4 630-640 cui:C0079904 denotes NF-kappa B
E6-ab-4 658-661 cui:C0019682 denotes HIV
E7-ab-4 662-675 cui:C0040649 denotes transcription
E8-ab-4 686-698 cui:C0003402 denotes antioxidants
T5 686-732 ISA denotes antioxidants can be used as therapeutic agents
T6 686-732 ISA denotes antioxidants can be used as therapeutic agents
T10 686-732 TREATS denotes antioxidants can be used as therapeutic agents
T11 686-732 TREATS denotes antioxidants can be used as therapeutic agents
E9-ab-4 714-732 cui:C1611640 denotes therapeutic agents
T9 733-736 TREATS denotes for
E10-ab-4 737-741 cui:C0001175 denotes AIDS
E1-ab-5 757-771 cui:C0376448 denotes Jurkat T cells
E2-ab-5 783-788 cui:C0007634 denotes cells
E3-ab-5 800-807 cui:C0205296 denotes natural
E4-ab-5 808-813 cui:C0038734 denotes thiol
E5-ab-5 814-825 cui:C0003402 denotes antioxidant
T12 814-844 ISA denotes antioxidant, alpha-lipoic acid
T17 814-844 STIMULATES denotes antioxidant, alpha-lipoic acid
E6-ab-5 827-844 cui:C0023791 denotes alpha-lipoic acid
E7-ab-5 859-870 cui:C1292856 denotes stimulation
T13 859-870 AUGMENTS denotes stimulation
E8-ab-5 874-879 cui:C0007634 denotes cells
E9-ab-5 901-911 cui:C0079904 denotes NF-kappa B
T14 912-922 STIMULATES denotes activation
T15 923-930 AUGMENTS denotes induced
T16 923-930 AUGMENTS denotes induced
E10-ab-5 934-961 cui:C1448177 denotes tumor necrosis factor-alpha
E11-ab-5 979-1010 cui:C0039654 denotes phorbol 12-myristate 13-acetate
E1-ab-6 1027-1037 cui:C0243077 denotes inhibitory
E2-ab-6 1048-1065 cui:C0023791 denotes alpha-lipoic acid
E3-ab-6 1082-1086 cui:C0442824 denotes very
E4-ab-6 1087-1093 cui:C0237399 denotes potent
E5-ab-6 1124-1132 cui:C0205197 denotes complete
E6-ab-6 1176-1192 cui:C0001047 denotes N-acetylcysteine
E1-ab-7 1200-1207 cui:C1274040 denotes results
E2-ab-7 1222-1239 cui:C0023791 denotes alpha-lipoic acid
E3-ab-7 1247-1256 cui:C1280500 denotes effective
T18 1257-1259 ASSOCIATED_WITH denotes in
E4-ab-7 1260-1264 cui:C0001175 denotes AIDS
E5-ab-7 1265-1277 cui:C0039796 denotes therapeutics
R1 E1-ti-1 T1 subjectOf Alpha-lipoic acid,activation
R10 E9-ab-4 T5 objectOf therapeutic agents,antioxidants can be used as therapeutic agents
R11 E3-ab-4 T6 subjectOf antioxidants,antioxidants can be used as therapeutic agents
R12 E9-ab-4 T6 objectOf therapeutic agents,antioxidants can be used as therapeutic agents
R13 E8-ab-4 T7 subjectOf antioxidants,activation
R14 E5-ab-4 T7 objectOf NF-kappa B,activation
R15 E3-ab-4 T8 subjectOf antioxidants,activation
R16 E5-ab-4 T8 objectOf NF-kappa B,activation
R17 E9-ab-4 T9 subjectOf therapeutic agents,for
R18 E10-ab-4 T9 objectOf AIDS,for
R19 E8-ab-4 T10 subjectOf antioxidants,antioxidants can be used as therapeutic agents
R2 E4-ti-1 T1 objectOf NF-kappa B,activation
R20 E10-ab-4 T10 objectOf AIDS,antioxidants can be used as therapeutic agents
R21 E3-ab-4 T11 subjectOf antioxidants,antioxidants can be used as therapeutic agents
R22 E10-ab-4 T11 objectOf AIDS,antioxidants can be used as therapeutic agents
R23 E6-ab-5 T12 subjectOf alpha-lipoic acid,"antioxidant, alpha-lipoic acid"
R24 E5-ab-5 T12 objectOf antioxidant,"antioxidant, alpha-lipoic acid"
R25 E6-ab-5 T13 subjectOf alpha-lipoic acid,stimulation
R26 E8-ab-5 T13 objectOf cells,stimulation
R27 E5-ab-5 T14 subjectOf antioxidant,activation
R28 E9-ab-5 T14 objectOf NF-kappa B,activation
R29 E10-ab-5 T15 subjectOf tumor necrosis factor-alpha,induced
R3 E2-ab-1 T2 subjectOf infection,results
R30 E1-ab-5 T15 objectOf Jurkat T cells,induced
R31 E11-ab-5 T16 subjectOf phorbol 12-myristate 13-acetate,induced
R32 E1-ab-5 T16 objectOf Jurkat T cells,induced
R33 E6-ab-5 T17 subjectOf alpha-lipoic acid,"antioxidant, alpha-lipoic acid"
R34 E9-ab-5 T17 objectOf NF-kappa B,"antioxidant, alpha-lipoic acid"
R35 E2-ab-7 T18 subjectOf alpha-lipoic acid,in
R36 E4-ab-7 T18 objectOf AIDS,in
R4 E1-ab-1 T2 objectOf Acquired immunodeficiency syndrome,results
R5 E6-ab-2 T3 subjectOf transcriptional activator,regulate
R6 E9-ab-2 T3 objectOf HIV activation,regulate
R7 E3-ab-3 T4 subjectOf reactive oxygen species,activation
R8 E5-ab-3 T4 objectOf NF-kappa B,activation
R9 E8-ab-4 T5 subjectOf antioxidants,antioxidants can be used as therapeutic agents